NASDAQ · Drug Manufacturers - Specialty & Generic

IRWD (IRWD) Stock

$4.29 +0.82% NASDAQ: IRWD Healthcare

Valuation

MetricValue
Price$4.29
Market Cap$705.37M
P/E Ratio5.39
P/B Ratio-4.39
P/S Ratio1.81
EPS (TTM)$0.62
52-Week High$5.78
52-Week Low$1.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.40%
ROA45.55%
ROCE93.58%
Gross Margin40.20%
Operating Margin40.20%
Net Margin33.36%
Debt/Equity-2.45
Current Ratio1.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$414.0M$411.0M$443.0M$351.0M$296.0M
Operating Profit$232.0M$250.0M$-945.0M$93.0M$119.0M
Net Profit$528.0M$175.0M$-1.0B$1.0M$24.0M
EPS$3.21$0.96$-6.45$0.01$0.15
Op Margin56.1%61.0%-213.5%26.5%40.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.1B$1.1B$471.0M$351.0M$397.0M
Total Liabilities$521.0M$448.0M$817.0M$652.0M$659.0M
Cash$620.0M$656.0M$92.0M$89.0M$215.0M
Borrowings$476.0M$416.0M$716.0M$599.0M$598.0M

Latest News

BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains? Zacks · Jul 8, 2026 4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues Zacks · Jul 8, 2026 ​Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum Insider Monkey · Jul 3, 2026 Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker Zacks · Jun 26, 2026 5 Small Drug Stocks to Invest in Amid a Biotech Comeback Zacks · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$262.0M$274.0M$183.0M$104.0M$127.0M
Investing Cash Flow$-1.0M$0$-1.0B$0$0
Financing Cash Flow$-5.0M$-117.0M$-29.0M$-3.0M$0
Net Cash Flow$257.0M$36.0M$-566.0M$-4.0M$127.0M
Free Cash Flow$262.0M$274.0M$183.0M$103.0M$127.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA4.24
FCF Yield26.28%
Quick Ratio6.06
Interest Coverage7.23
Return 1Y335.63%
Return 3Y-64.74%
Return 5Y-68.34%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACB $4.03 -0.49% 115.33 $249.63M 0.00%
ALDX $1.47 -0.68% -2.77 $88.67M 0.00%
BIOA $9.56 +0.63% -9.34 $359.93M 0.00%
CGC $0.97 -2.25% -0.20 $410.59M 0.00%
CLLSCellectis S.A. $2.81 -2.26% -4.14 $282.17M 0.00%

About IRWD

IRWD is led by CEO Thomas A. McCourt, employs 253 people, headquartered in US, publicly traded since 2010.

IRWD stock trades at $4.29 with a market capitalization of $705.37M. The stock is valued at a price-to-earnings (P/E) ratio of 5.39, price-to-book of -4.39, price-to-sales of 1.81. Over the past 52 weeks the stock has ranged between $1.01 and $5.78, and currently trades 25.8% below its 52-week high.

On profitability, IRWD generates a return on equity (ROE) of -57.40%, return on capital employed of 93.58%, an operating margin of 40.20%, a net profit margin of 33.36%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1158.17 +0.12% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.73 +1.33% UNH Medical - Healthcare Plans $395.82 +1.65% NVS Drug Manufacturers - General $161.42 +6.16% AZN Drug Manufacturers - General $161.93 -0.12% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.92 -2.46% NVO Biotechnology $45.15 -0.41% ABT Medical - Devices $109.15 -1.10% GILD Drug Manufacturers - General $148.93 +1.77%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides